Clean Power Hyd Regulatory News (CPH2)

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

4 April 2022

Clean Power Hydrogen Plc

("CPH2", the "Company" or the "Group")

Additional purchase order from existing customer

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce that it has entered into a purchase order with AFCryo, a New Zealand based manufacturer of composite cryostats and cryogenic cooling systems, for the sale of a 1MW MFE220 electrolyser unit to be delivered in early 2023. This is the second 1MW electrolyser unit that AFCryo has purchased within 18 months.

CPH2 has an established working relationship with AFCryo and utilises the AFCryo cryogenic cooling system in its MFEs. CPH2's MFE220 runs with 1MW of input power with eight stacks and is capable of producing 450kg/day of high purity hydrogen output. The stack is made of ubiquitous materials and generates a mixed wet gas. The wet gas then passes through a series of driers before entering the separation unit where the oxygen is cryogenically separated from the hydrogen. The cold energy from this cryogenic process is captured via a heat exchanger and used to super-cool the incoming mixed gas, thereby improving the efficiency of the process. The MFE is scalable, easily transported and assembled in the required scale and specification for the end customer.

In May 2021 AFCryo placed an order for its first 1MW MFE220 electrolyser, with delivery anticipated in September 2022. Additionally, in 2021, AFCryo was appointed as a non-exclusive agent for the marketing and sale of the CPH2 electrolyser system in Australia, New Zealand and the Pacific Islands.

Both of these electrolysers will be used as part of the decarbonisation of New Zealand's heavy transport fleet.

Jon Duffy, Chief Executive Officer of CPH2, commented:

"We are delighted to receive our second 1MW MFE order from AFCryo, another positive commercial step for the Company. We have a strong working relationship with AFCryo as the Group utilises its cryogenic cooling system in our electrolysers and the further order of another electrolyser from the Group shows the trust in each other's products. We very much look forward to continuing our relationship with AFCryo and continuing our partnership in the region."

Hugh Reynolds, Technical Director of AFCryo, commented:

"I am delighted to announce another purchase order with CHP2 whereby our close commercial relationship and appreciation of each other's technical standards, mean that we can enter into a purchase order knowing the high quality and efficiency of the product. We see CPH2's membrane free technology as something which is potentially game changing on a global scale for green hydrogen manufacture and we are very happy to be both a supplier and customer to the Group."

For more information, please contact:

To find out more, please visit: https://www.cph2.com

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

Overview of AFCryo

AFCryo is a technology development and commercialisation company specialising in superconductivity, cryogenics and advanced composite structures. It has an underlying philosophy of supplying solutions that are environmentally friendly and energy efficient. This includes using their patented DPWG cryocoolers for on-site production of medical oxygen, and liquid nitrogen for artificial insemination programs, science, and general industry. AFCryo have a particular focus on Liquid Hydrogen, supplying mid-scale liquefaction to complement their onboard storage and dispensing systems. This is seen as critical for enabling liquid hydrogen as a viable fuel. AFCryo is a privately owned, New Zealand based company.